Possible anticancer agents: QSAR analogs of glutamamide: Synthesis and pharmacological activity of 1,5- N, N′-disubstituted-2-(substituted benzenesulphonyl) glutamamides

Based on our earlier QSAR prediction, a series of designed QSAR analogs of 1,5- N, N′-disubstituted-2-(substituted benzenesulphonyl) glutamamides were synthesized as possible anticancer agents. Inhibitions of tumor cell proliferation of the compounds were tested in tumor cell line IMR-32. Anticancer...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of medicinal chemistry 2009, Vol.44 (1), p.70-82
Hauptverfasser: Samanta, Soma, Alam, Sk. Mahasin, Panda, Parthasarathi, Jha, Tarun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 82
container_issue 1
container_start_page 70
container_title European journal of medicinal chemistry
container_volume 44
creator Samanta, Soma
Alam, Sk. Mahasin
Panda, Parthasarathi
Jha, Tarun
description Based on our earlier QSAR prediction, a series of designed QSAR analogs of 1,5- N, N′-disubstituted-2-(substituted benzenesulphonyl) glutamamides were synthesized as possible anticancer agents. Inhibitions of tumor cell proliferation of the compounds were tested in tumor cell line IMR-32. Anticancer activities of these compounds were also evaluated on Swiss Albino mice against Ehrlich Ascites Carcinoma (EAC) cells. Tumor weight inhibition and tumor cell inhibition were considered as anticancer activity parameters. QSAR analysis of these compounds was performed on the basis of a set of descriptors like physicochemical, topological, quantum chemical and DRAGON whole molecular descriptors. The study showed that the increase of length of substituent at R 2 position and the increase of dipole moment of the molecule decrease the anticancer activity of these compounds, presence of bromine atom at R 3 position and hydrophilic substitution at R 2 position are advantageous to the activity. Nucleophilic attack at atom number 14 is advantageous and electrophilic attack at atom number 15 is detrimental to anticancer activity. Atom number 2 is important and may be involved in dispersive interactions of the compounds with enzymes. The results offer an opportunity for further tailoring of these analogs for an active member. [Display omitted] Based on our earlier QSAR prediction, a series of QSAR analogs of 1,5- N, N′-disubstituted-2-(substituted benzenesulphonyl) glutamamides were synthesized, pharmacologically evaluated and QSAR analysis of these compounds was performed. The study showed importance of particular atoms in dispersive interaction of the compounds with the enzymes, as well as the substitution patterns required for improved activity which may offer an opportunity for further tailoring of these analogs for an active member.
doi_str_mv 10.1016/j.ejmech.2008.03.008
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66783641</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0223523408001402</els_id><sourcerecordid>66783641</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-1d832c10cd232bb8dfb048c7d95962334d1313c81bd75c695a23922923060a383</originalsourceid><addsrcrecordid>eNp9kctu1DAYhS0EotPCGyDkDQikJvy2EyfpAqmquElVuRTWlmP_mfEol8F2Kk1XvA87HoknwaMZQVesjmx959g6h5AnDHIGTL5a57ge0KxyDlDnIPIk98iCVbLOBC-L-2QBnIus5KI4IschrAGglAAPyRGri1KKii_Iz09TCK7tkeoxOqNHg57qJY4xnNHP1-df0r3up2WgU0eX_Rz1oAdn8Yxeb8e4wuBCIizdrLQftJkSmlJ6qk10Ny5udzZ2Wmb06pRe_f7xK7MuzG2ILs4RbcazF3eOtMXxFkcMc79ZTeO2f3n3yfCIPOh0H_DxQU_It7dvvl68zy4_vvtwcX6ZGdFAzJitBTcMjOWCt21tuxaK2lS2KRvJhSgsE0yYmrW2Ko1sSs1Fw3nDBUjQohYn5Pk-d-On7zOGqAYXDPa9HnGag5KyqoUsWAKLPWh8atFjpzbeDdpvFQO1G0mt1X4ktRtJgVBJku3pIX9uB7T_TIdVEvDsAOiQyux8msWFvxxnUDHJy8S93nOY2rhx6FUwDtOE1nk0UdnJ_f8nfwBkfLRh</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66783641</pqid></control><display><type>article</type><title>Possible anticancer agents: QSAR analogs of glutamamide: Synthesis and pharmacological activity of 1,5- N, N′-disubstituted-2-(substituted benzenesulphonyl) glutamamides</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Samanta, Soma ; Alam, Sk. Mahasin ; Panda, Parthasarathi ; Jha, Tarun</creator><creatorcontrib>Samanta, Soma ; Alam, Sk. Mahasin ; Panda, Parthasarathi ; Jha, Tarun</creatorcontrib><description>Based on our earlier QSAR prediction, a series of designed QSAR analogs of 1,5- N, N′-disubstituted-2-(substituted benzenesulphonyl) glutamamides were synthesized as possible anticancer agents. Inhibitions of tumor cell proliferation of the compounds were tested in tumor cell line IMR-32. Anticancer activities of these compounds were also evaluated on Swiss Albino mice against Ehrlich Ascites Carcinoma (EAC) cells. Tumor weight inhibition and tumor cell inhibition were considered as anticancer activity parameters. QSAR analysis of these compounds was performed on the basis of a set of descriptors like physicochemical, topological, quantum chemical and DRAGON whole molecular descriptors. The study showed that the increase of length of substituent at R 2 position and the increase of dipole moment of the molecule decrease the anticancer activity of these compounds, presence of bromine atom at R 3 position and hydrophilic substitution at R 2 position are advantageous to the activity. Nucleophilic attack at atom number 14 is advantageous and electrophilic attack at atom number 15 is detrimental to anticancer activity. Atom number 2 is important and may be involved in dispersive interactions of the compounds with enzymes. The results offer an opportunity for further tailoring of these analogs for an active member. [Display omitted] Based on our earlier QSAR prediction, a series of QSAR analogs of 1,5- N, N′-disubstituted-2-(substituted benzenesulphonyl) glutamamides were synthesized, pharmacologically evaluated and QSAR analysis of these compounds was performed. The study showed importance of particular atoms in dispersive interaction of the compounds with the enzymes, as well as the substitution patterns required for improved activity which may offer an opportunity for further tailoring of these analogs for an active member.</description><identifier>ISSN: 0223-5234</identifier><identifier>EISSN: 1768-3254</identifier><identifier>DOI: 10.1016/j.ejmech.2008.03.008</identifier><identifier>PMID: 18456372</identifier><identifier>CODEN: EJMCA5</identifier><language>eng</language><publisher>Kidlington: Elsevier Masson SAS</publisher><subject>Amides - chemical synthesis ; Amides - pharmacology ; Animals ; Anticancer activity ; Antineoplastic agents ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Biological and medical sciences ; Carcinoma, Ehrlich Tumor - drug therapy ; Carcinoma, Ehrlich Tumor - pathology ; Cell Line, Tumor ; Cell Proliferation - drug effects ; Cluster analysis ; Drug Screening Assays, Antitumor ; EAC ; General aspects ; Glutamamide ; Glutamates - chemical synthesis ; Glutamates - chemistry ; Glutamates - pharmacology ; Humans ; IMR-32 ; Medical sciences ; Mice ; Pharmacology. Drug treatments ; QSAR ; Quantitative Structure-Activity Relationship ; Tumor Burden - drug effects</subject><ispartof>European journal of medicinal chemistry, 2009, Vol.44 (1), p.70-82</ispartof><rights>2008 Elsevier Masson SAS</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-1d832c10cd232bb8dfb048c7d95962334d1313c81bd75c695a23922923060a383</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejmech.2008.03.008$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,4010,27904,27905,27906,45976</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21071625$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18456372$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Samanta, Soma</creatorcontrib><creatorcontrib>Alam, Sk. Mahasin</creatorcontrib><creatorcontrib>Panda, Parthasarathi</creatorcontrib><creatorcontrib>Jha, Tarun</creatorcontrib><title>Possible anticancer agents: QSAR analogs of glutamamide: Synthesis and pharmacological activity of 1,5- N, N′-disubstituted-2-(substituted benzenesulphonyl) glutamamides</title><title>European journal of medicinal chemistry</title><addtitle>Eur J Med Chem</addtitle><description>Based on our earlier QSAR prediction, a series of designed QSAR analogs of 1,5- N, N′-disubstituted-2-(substituted benzenesulphonyl) glutamamides were synthesized as possible anticancer agents. Inhibitions of tumor cell proliferation of the compounds were tested in tumor cell line IMR-32. Anticancer activities of these compounds were also evaluated on Swiss Albino mice against Ehrlich Ascites Carcinoma (EAC) cells. Tumor weight inhibition and tumor cell inhibition were considered as anticancer activity parameters. QSAR analysis of these compounds was performed on the basis of a set of descriptors like physicochemical, topological, quantum chemical and DRAGON whole molecular descriptors. The study showed that the increase of length of substituent at R 2 position and the increase of dipole moment of the molecule decrease the anticancer activity of these compounds, presence of bromine atom at R 3 position and hydrophilic substitution at R 2 position are advantageous to the activity. Nucleophilic attack at atom number 14 is advantageous and electrophilic attack at atom number 15 is detrimental to anticancer activity. Atom number 2 is important and may be involved in dispersive interactions of the compounds with enzymes. The results offer an opportunity for further tailoring of these analogs for an active member. [Display omitted] Based on our earlier QSAR prediction, a series of QSAR analogs of 1,5- N, N′-disubstituted-2-(substituted benzenesulphonyl) glutamamides were synthesized, pharmacologically evaluated and QSAR analysis of these compounds was performed. The study showed importance of particular atoms in dispersive interaction of the compounds with the enzymes, as well as the substitution patterns required for improved activity which may offer an opportunity for further tailoring of these analogs for an active member.</description><subject>Amides - chemical synthesis</subject><subject>Amides - pharmacology</subject><subject>Animals</subject><subject>Anticancer activity</subject><subject>Antineoplastic agents</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Carcinoma, Ehrlich Tumor - drug therapy</subject><subject>Carcinoma, Ehrlich Tumor - pathology</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation - drug effects</subject><subject>Cluster analysis</subject><subject>Drug Screening Assays, Antitumor</subject><subject>EAC</subject><subject>General aspects</subject><subject>Glutamamide</subject><subject>Glutamates - chemical synthesis</subject><subject>Glutamates - chemistry</subject><subject>Glutamates - pharmacology</subject><subject>Humans</subject><subject>IMR-32</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Pharmacology. Drug treatments</subject><subject>QSAR</subject><subject>Quantitative Structure-Activity Relationship</subject><subject>Tumor Burden - drug effects</subject><issn>0223-5234</issn><issn>1768-3254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kctu1DAYhS0EotPCGyDkDQikJvy2EyfpAqmquElVuRTWlmP_mfEol8F2Kk1XvA87HoknwaMZQVesjmx959g6h5AnDHIGTL5a57ge0KxyDlDnIPIk98iCVbLOBC-L-2QBnIus5KI4IschrAGglAAPyRGri1KKii_Iz09TCK7tkeoxOqNHg57qJY4xnNHP1-df0r3up2WgU0eX_Rz1oAdn8Yxeb8e4wuBCIizdrLQftJkSmlJ6qk10Ny5udzZ2Wmb06pRe_f7xK7MuzG2ILs4RbcazF3eOtMXxFkcMc79ZTeO2f3n3yfCIPOh0H_DxQU_It7dvvl68zy4_vvtwcX6ZGdFAzJitBTcMjOWCt21tuxaK2lS2KRvJhSgsE0yYmrW2Ko1sSs1Fw3nDBUjQohYn5Pk-d-On7zOGqAYXDPa9HnGag5KyqoUsWAKLPWh8atFjpzbeDdpvFQO1G0mt1X4ktRtJgVBJku3pIX9uB7T_TIdVEvDsAOiQyux8msWFvxxnUDHJy8S93nOY2rhx6FUwDtOE1nk0UdnJ_f8nfwBkfLRh</recordid><startdate>2009</startdate><enddate>2009</enddate><creator>Samanta, Soma</creator><creator>Alam, Sk. Mahasin</creator><creator>Panda, Parthasarathi</creator><creator>Jha, Tarun</creator><general>Elsevier Masson SAS</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2009</creationdate><title>Possible anticancer agents: QSAR analogs of glutamamide: Synthesis and pharmacological activity of 1,5- N, N′-disubstituted-2-(substituted benzenesulphonyl) glutamamides</title><author>Samanta, Soma ; Alam, Sk. Mahasin ; Panda, Parthasarathi ; Jha, Tarun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-1d832c10cd232bb8dfb048c7d95962334d1313c81bd75c695a23922923060a383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Amides - chemical synthesis</topic><topic>Amides - pharmacology</topic><topic>Animals</topic><topic>Anticancer activity</topic><topic>Antineoplastic agents</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Carcinoma, Ehrlich Tumor - drug therapy</topic><topic>Carcinoma, Ehrlich Tumor - pathology</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation - drug effects</topic><topic>Cluster analysis</topic><topic>Drug Screening Assays, Antitumor</topic><topic>EAC</topic><topic>General aspects</topic><topic>Glutamamide</topic><topic>Glutamates - chemical synthesis</topic><topic>Glutamates - chemistry</topic><topic>Glutamates - pharmacology</topic><topic>Humans</topic><topic>IMR-32</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Pharmacology. Drug treatments</topic><topic>QSAR</topic><topic>Quantitative Structure-Activity Relationship</topic><topic>Tumor Burden - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Samanta, Soma</creatorcontrib><creatorcontrib>Alam, Sk. Mahasin</creatorcontrib><creatorcontrib>Panda, Parthasarathi</creatorcontrib><creatorcontrib>Jha, Tarun</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Samanta, Soma</au><au>Alam, Sk. Mahasin</au><au>Panda, Parthasarathi</au><au>Jha, Tarun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Possible anticancer agents: QSAR analogs of glutamamide: Synthesis and pharmacological activity of 1,5- N, N′-disubstituted-2-(substituted benzenesulphonyl) glutamamides</atitle><jtitle>European journal of medicinal chemistry</jtitle><addtitle>Eur J Med Chem</addtitle><date>2009</date><risdate>2009</risdate><volume>44</volume><issue>1</issue><spage>70</spage><epage>82</epage><pages>70-82</pages><issn>0223-5234</issn><eissn>1768-3254</eissn><coden>EJMCA5</coden><abstract>Based on our earlier QSAR prediction, a series of designed QSAR analogs of 1,5- N, N′-disubstituted-2-(substituted benzenesulphonyl) glutamamides were synthesized as possible anticancer agents. Inhibitions of tumor cell proliferation of the compounds were tested in tumor cell line IMR-32. Anticancer activities of these compounds were also evaluated on Swiss Albino mice against Ehrlich Ascites Carcinoma (EAC) cells. Tumor weight inhibition and tumor cell inhibition were considered as anticancer activity parameters. QSAR analysis of these compounds was performed on the basis of a set of descriptors like physicochemical, topological, quantum chemical and DRAGON whole molecular descriptors. The study showed that the increase of length of substituent at R 2 position and the increase of dipole moment of the molecule decrease the anticancer activity of these compounds, presence of bromine atom at R 3 position and hydrophilic substitution at R 2 position are advantageous to the activity. Nucleophilic attack at atom number 14 is advantageous and electrophilic attack at atom number 15 is detrimental to anticancer activity. Atom number 2 is important and may be involved in dispersive interactions of the compounds with enzymes. The results offer an opportunity for further tailoring of these analogs for an active member. [Display omitted] Based on our earlier QSAR prediction, a series of QSAR analogs of 1,5- N, N′-disubstituted-2-(substituted benzenesulphonyl) glutamamides were synthesized, pharmacologically evaluated and QSAR analysis of these compounds was performed. The study showed importance of particular atoms in dispersive interaction of the compounds with the enzymes, as well as the substitution patterns required for improved activity which may offer an opportunity for further tailoring of these analogs for an active member.</abstract><cop>Kidlington</cop><pub>Elsevier Masson SAS</pub><pmid>18456372</pmid><doi>10.1016/j.ejmech.2008.03.008</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0223-5234
ispartof European journal of medicinal chemistry, 2009, Vol.44 (1), p.70-82
issn 0223-5234
1768-3254
language eng
recordid cdi_proquest_miscellaneous_66783641
source MEDLINE; Elsevier ScienceDirect Journals
subjects Amides - chemical synthesis
Amides - pharmacology
Animals
Anticancer activity
Antineoplastic agents
Antineoplastic Agents - chemistry
Antineoplastic Agents - pharmacology
Biological and medical sciences
Carcinoma, Ehrlich Tumor - drug therapy
Carcinoma, Ehrlich Tumor - pathology
Cell Line, Tumor
Cell Proliferation - drug effects
Cluster analysis
Drug Screening Assays, Antitumor
EAC
General aspects
Glutamamide
Glutamates - chemical synthesis
Glutamates - chemistry
Glutamates - pharmacology
Humans
IMR-32
Medical sciences
Mice
Pharmacology. Drug treatments
QSAR
Quantitative Structure-Activity Relationship
Tumor Burden - drug effects
title Possible anticancer agents: QSAR analogs of glutamamide: Synthesis and pharmacological activity of 1,5- N, N′-disubstituted-2-(substituted benzenesulphonyl) glutamamides
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T13%3A20%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Possible%20anticancer%20agents:%20QSAR%20analogs%20of%20glutamamide:%20Synthesis%20and%20pharmacological%20activity%20of%201,5-%20N,%20N%E2%80%B2-disubstituted-2-(substituted%20benzenesulphonyl)%20glutamamides&rft.jtitle=European%20journal%20of%20medicinal%20chemistry&rft.au=Samanta,%20Soma&rft.date=2009&rft.volume=44&rft.issue=1&rft.spage=70&rft.epage=82&rft.pages=70-82&rft.issn=0223-5234&rft.eissn=1768-3254&rft.coden=EJMCA5&rft_id=info:doi/10.1016/j.ejmech.2008.03.008&rft_dat=%3Cproquest_cross%3E66783641%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66783641&rft_id=info:pmid/18456372&rft_els_id=S0223523408001402&rfr_iscdi=true